Home > National Drug Code (NDC) > Black Willow

Black Willow - 49288-0610-2 - (Black Willow)

Alphabetical Index


Drug Information of Black Willow

Product NDC: 49288-0610
Proprietary Name: Black Willow
Non Proprietary Name: Black Willow
Active Ingredient(s): .05    g/mL & nbsp;   Black Willow
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Black Willow

Product NDC: 49288-0610
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19740323

Package Information of Black Willow

Package NDC: 49288-0610-2
Package Description: 5 mL in 1 VIAL, MULTI-DOSE (49288-0610-2)

NDC Information of Black Willow

NDC Code 49288-0610-2
Proprietary Name Black Willow
Package Description 5 mL in 1 VIAL, MULTI-DOSE (49288-0610-2)
Product NDC 49288-0610
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Black Willow
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19740323
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name SALIX NIGRA POLLEN
Strength Number .05
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Black Willow


General Information